ATF4 and esophageal squamous cell carcinoma: Similarly, PERK also contributes to ECM reorganization in breast cancer and overexpression of ATF4, which is a component of PERK pathway, induces cell invasion and metastasis, stimulating MMP2 and MMP7 expression in ESCC [13].